Purchase Order 75N98026P01090
- Not listed
- This is a $12,500 firm fixed-price purchase order contract awarded by the National Human Genome Research Institute, a civilian agency within the U.S. Department of Health and Human Services, to Berry Consultants LLC, a for-profit limited liability company. The contract is for a simulated clinical trial to evaluate disease progression modeling and potential treatment outcomes for patients with pulmonary fibrosis. The contract does not have a set-aside designation and is scheduled for completion...
- This is a delivery order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Heart, Lung, and Blood Institute to Berry Consultants LLC, a for-profit limited liability company. The $64,454.21 cost-plus-fixed-fee contract is for consultative services related to innovative clinical trials, as part of the ICTR Task Area B program. This contract does not utilize any small business set-aside designation. Berry Consultants has received multiple...
- This is a delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) to Berry Consultants LLC, a for-profit limited liability company. The contract, valued at $152,194.72, is for Berry Consultants to provide consultative services related to innovative clinical trials under NHLBI's Innovative Clinical Trials Resource (ICTR) program. The contract does not have a small business set-aside...
- <p>The National Human Genome Research Institute issued a delivery order to The Emmes Company, LLC on July 1, 2026, with a ceiling value of $115,000 for statistical expertise supporting the Small Business Research and Business (SBRB) initiative.</p> <p>Place of performance is Bethesda, MD. The order carries an ultimate completion date of June 30, 2027. Work will be performed on a time and materials basis with no set-aside applied.</p>
- <p>The National Heart, Lung, and Blood Institute awarded a purchase order to The Broad Institute, Inc. for $156,250 on June 5, 2026, for whole genome sequencing of sickle cell patient blood samples. Work is performed in Cambridge, Massachusetts, with an ultimate completion date of June 4, 2027. The order is firm fixed price with no small business set-aside.</p>
- <p>The National Human Genome Research Institute issued a delivery order to Fisher Bioservices Inc. on May 30, 2018, with a ceiling value of $18,530.81 for biorepository and scientific services.</p> <p>The order is placed against the GSA Multiple Award Schedule (Scientific Equipment and Services, FSS-66). Place of performance is Bethesda, Maryland. The order has a firm fixed price structure with an ultimate completion date of May 31, 2019. No set-aside was used for this award.</p>
- <p>The National Human Genome Research Institute issued a purchase order to Fox Chase Cancer Center on December 2, 2016, for sequencing services valued at $3,840.00. Place of performance is Bethesda, Maryland. The order carries a firm fixed price structure and is scheduled for completion by December 31, 2016.</p>
- This is a firm fixed-price purchase order awarded by the National Human Genome Research Institute (NHGRI), a civilian agency, to SBH Sciences Inc. on June 12, 2018. The contract has a ceiling value of $8,300 and an ultimate completion date of August 31, 2020. The contract is not designated as a set-aside. Based on the information provided, this award appears to be for a specific product or service required by NHGRI, which is the lead National Institutes of Health (NIH) institute responsible...
- <p>The National Human Genome Research Institute issued a delivery order to Fisher Bioservices Inc. on January 14, 2013, with a ceiling value of $11,999.79 for biorepository and clinical materials services.</p> <p>The order is placed under the Scientific Equipment and Services (FSS-66) GSA Schedule. Place of performance is Rockville, MD. Ultimate completion date is September 30, 2013. The order is priced on a firm fixed-price basis with no set-aside designation.</p>
- <p>This is a $11,600 firm-fixed-price purchase order awarded by the National Heart Lung and Blood Institute, a civilian agency, to Bridge Informatics, Inc. for bioinformatic analysis of next-generation sequencing (NGS) data to identify nucleic acid motifs involved in the assembly of stress particles isolated from human cells. The contract has an ultimate completion date of January 23, 2026 and was awarded on July 23, 2025. The contract is not associated with a set-aside program.</p>
The National Human Genome Research Institute awarded a purchase order to Berry Consultants LLC for $50,000 on July 29, 2026, for clinical trial design services in hereditary pulmonary stenosis pulmonary fibrosis. Work is performed in West Lake Hills, Texas. The scope includes characterizing disease progression using available natural history, observational, and clinical trial data; evaluating candidate endpoints and analysis methods; and recommending a design strategy for future interventional trials. The order carries a firm-fixed-price structure with an ultimate completion date of January 28, 2027. The award emerged from a pre-solicitation posted July 12, 2026, designated total small business set-aside, with responses due July 21, 2026. NIH announced a sole-source intent to Berry Consultants under FAR 6.302-1, citing the firm's prior modeling work on the NIH HPS cohort and possession of preliminary data from previous contracts. The procurement is classified under NAICS 541690 (Other Scientific and Technical Consulting Services) and PSC R412 (Support-Professional: Simulation).
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Clinical trial design for HPS pulmonary fibrosis | 75N98026Q00776 | Department of Health and Human Services National Institutes of Health Office of Logisitics and Acquisition Operations | Pre-Solicitation 1/1 | 7/12/26, 3:34 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $50.0k | 7/21/26 |